DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

All news

Neutral impactCompany

Gland Pharma Limited — Change in Director(s)

NSE 12 hrs ago·20 Jul 2026, 5:16 pm

Gland Pharma

Gland Pharma Limited has announced a change in its board of directors. The company has informed the stock exchanges that one or more individuals have been appointed or resigned from the board, marking a shift in its leadership structure.

This development is a routine corporate governance update. While board changes can sometimes signal strategic shifts or new leadership directions, they are not inherently negative. Investors should monitor the background of the new appointees to see if they bring specific expertise relevant to the company's future growth.

For now, the market reaction is likely to be muted. Investors should focus on the company's operational performance and quarterly results to gauge the true impact of this leadership transition.